Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
Pasquale Paolisso(CTO Andrea Alesini), Nazzareno Galiè(Azienda USL di Bologna), Carmine Pizzi(Azienda USL di Bologna), Renato Pascale(University of Bologna), Luca Bergamaschi(Ospedale G.B. Morgagni - L.Pierantoni), Benilde Cosmi(University of Bologna), Pierluigi Viale(Azienda USL di Bologna), Francesco Donati(University of Bologna), Maddalena Giannella(Hospital General Universitario Gregorio Marañón), Mauro Biffi(University of Bologna), Giulia Tesini(Humanitas University), Emanuela Concetta D’Angelo(Azienda USL di Bologna), Michele Bartoletti(University of Bologna), Sara Tedeschi(University of Bologna)
Cited by 75
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
(untitled)
|European Heart Journal|2004|1k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834